派博傳思國(guó)際中心

標(biāo)題: Titlebook: Hydrogen Sulfide in Kidney Diseases; A Novel Pharmacother George J. Dugbartey,Alp Sener Book 2023 The Editor(s) (if applicable) and The Aut [打印本頁(yè)]

作者: Conjecture    時(shí)間: 2025-3-21 17:23
書目名稱Hydrogen Sulfide in Kidney Diseases影響因子(影響力)




書目名稱Hydrogen Sulfide in Kidney Diseases影響因子(影響力)學(xué)科排名




書目名稱Hydrogen Sulfide in Kidney Diseases網(wǎng)絡(luò)公開度




書目名稱Hydrogen Sulfide in Kidney Diseases網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Hydrogen Sulfide in Kidney Diseases被引頻次




書目名稱Hydrogen Sulfide in Kidney Diseases被引頻次學(xué)科排名




書目名稱Hydrogen Sulfide in Kidney Diseases年度引用




書目名稱Hydrogen Sulfide in Kidney Diseases年度引用學(xué)科排名




書目名稱Hydrogen Sulfide in Kidney Diseases讀者反饋




書目名稱Hydrogen Sulfide in Kidney Diseases讀者反饋學(xué)科排名





作者: 完全    時(shí)間: 2025-3-21 23:57
FDA-Approved Hydrogen Sulfide Donor Drug and Its Clinical Applications in Nephrology,lar hypertension, renal ischemia-reperfusion injury, chronic kidney disease, and uremic pruritus, as well as the molecular mechanisms underlying these clinical applications and a future perspective in kidney transplantation.
作者: allergy    時(shí)間: 2025-3-22 03:04

作者: BLUSH    時(shí)間: 2025-3-22 08:19
eature redundancy and to improve the intelligibility of data mining results, a new wrapper method of feature selection based on random forest variables importance measures and support vector machine was proposed. The proposed method combined sequence backward searching approach and sequence forward
作者: cardiovascular    時(shí)間: 2025-3-22 11:55

作者: 托運(yùn)    時(shí)間: 2025-3-22 13:07
George J. Dugbarteytems biology, and drug discovery. However, no such database can be complete, and the chemical structure for a given compound is not necessarily consistent between databases. This paper presents ., a novel tool for resolving unique and correct molecular structures from database identifiers. . travers
作者: Obstruction    時(shí)間: 2025-3-22 19:08

作者: 胰臟    時(shí)間: 2025-3-22 23:20

作者: ADJ    時(shí)間: 2025-3-23 03:08
George J. Dugbarteyvalue to guiding and facilitating the treatment. Traditional methods, such as computed tomography (CT) and coronary computed tomography angiography (CCTA), are costly and harmful to humans. To address these issues, we proposed a multi-modal data fusion method of ultrasonic (US) images and electronic
作者: RAFF    時(shí)間: 2025-3-23 05:34

作者: Amnesty    時(shí)間: 2025-3-23 10:47

作者: NIL    時(shí)間: 2025-3-23 16:57
George J. Dugbartey,Hjalmar R. Bouma,Manujendra N. Saha,Ian Lobb,Robert H. Henning,Alp Sener in invertebrate animals, but the occurrence of such homotypic clusters of TFBSs (HCTs) in the human genome has remained largely unknown. To explore whether HCTs are also common in human and other vertebrates, we used known binding motifs for vertebrate TFs and a hidden Markov model-based approach t
作者: 個(gè)阿姨勾引你    時(shí)間: 2025-3-23 21:21

作者: cartilage    時(shí)間: 2025-3-24 00:05
George J. Dugbartey,Max Y. Zhang,Alp Senerne families and the evolution of those gene families inside a species tree, represents one of the most powerful computational techniques for reconstructing detailed histories of domain and gene family evolution in eukaryotic species. However, the DGS reconciliation framework allows for the reconcili
作者: 預(yù)感    時(shí)間: 2025-3-24 05:19
xt mining methods extract annotations from existing unstructured data descriptions and often provide inaccurate output that requires manual curation. Automatic data-based augmentation (generation of annotations on the base of expression data) can considerably improve the annotation quality and has n
作者: 極少    時(shí)間: 2025-3-24 10:04
Hydrogen Sulfide and the Renal System,cially among industrial workers. This is due to its ability to reversibly inhibit the activity of cytochrome . oxidase, a terminal enzyme of the mitochondrial electron transport chain. Recently, however, H.S has risen above its notorious public image and is now seen by researchers as an endogenously
作者: Omniscient    時(shí)間: 2025-3-24 13:19
Hydrogen Sulfide for Cisplatin- and Gentamicin-Induced Acute Kidney Injury,dney injury (AKI) is a major side effect of cisplatin therapy. While the antineoplastic action of cisplatin is due to formation of cisplatin-DNA cross-links, which damage rapidly dividing cancer cells upon binding to DNA, its nephrotoxic effect results from metabolic conversion of cisplatin into a n
作者: 放大    時(shí)間: 2025-3-24 15:26

作者: 十字架    時(shí)間: 2025-3-24 19:11
Hydrogen Sulfide for Diabetic Kidney Disease and Focal Segmental Glomerulosclerosis,rbidity and mortality among the diabetic population despite optimal management. Its clinical hallmark includes persistent hyperglycemia, hypercreatininemia, uremia, sustained albuminuria, renal hemodynamic changes, and elevated blood pressure. Histologically, DKD presents with excessive accumulation
作者: Myosin    時(shí)間: 2025-3-25 01:25
Hydrogen Sulfide for the Treatment of Hypertensive Nephropathy and Calcium-Based Nephrolithiasis,act on renal function. Uncontrolled hypertension causes chronic kidney disease, which progresses to end-stage renal disease and eventually loss of renal function. Unfortunately, the mechanism underlying the pathogenesis of hypertension and its associated nephropathy is still poorly understood. Also
作者: 取回    時(shí)間: 2025-3-25 06:16

作者: Progesterone    時(shí)間: 2025-3-25 07:45

作者: 減弱不好    時(shí)間: 2025-3-25 14:46

作者: 間接    時(shí)間: 2025-3-25 17:42
Hydrogen Sulfide Against Ischemia-Reperfusion Injury in Transplantation of Kidney and Other Transplor factor that increases acute tubular necrosis, decreases graft survival, and delays renal graft function. This complicates graft quality, posttransplant patient care, and kidney transplantation outcomes and therefore undermines the success of kidney transplantation. In this chapter, we present rec
作者: Vsd168    時(shí)間: 2025-3-25 20:00
FDA-Approved Hydrogen Sulfide Donor Drug and Its Clinical Applications in Nephrology,hird member of the gasotransmitter family. STS is currently used in the clinical treatment of acute cyanide poisoning, cisplatin toxicities in cancer therapy, and calciphylaxis in dialysis patients. Burgeoning evidence shows that STS has antioxidant and anti-inflammatory properties, making it a pote
作者: NAUT    時(shí)間: 2025-3-26 02:24

作者: 挫敗    時(shí)間: 2025-3-26 04:55
George J. Dugbartey,Alp SenerCovers the latest experimental evidence of hydrogen sulfide for cisplatin-induced acute kidney injury.Provides updates on hydrogen sulfide as a novel pharmacotherapy for chronic kidney disease.Present
作者: AUGUR    時(shí)間: 2025-3-26 09:36

作者: carbohydrate    時(shí)間: 2025-3-26 15:06
978-3-031-44043-4The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
作者: 迷住    時(shí)間: 2025-3-26 19:16

作者: 說不出    時(shí)間: 2025-3-26 22:23
Hydrogen Sulfide and the Renal System,udies have demonstrated that at low micromolar concentrations, H.S plays a complex and essential role in normal renal function, and dysregulation of its production has been implicated in various renal pathologies. In addition, exogenous H.S administration has been reported to exhibit important thera
作者: 意外的成功    時(shí)間: 2025-3-27 02:03

作者: CHURL    時(shí)間: 2025-3-27 06:32

作者: defenses    時(shí)間: 2025-3-27 10:22
Hydrogen Sulfide for Diabetic Kidney Disease and Focal Segmental Glomerulosclerosis, cytokines, activation of fibroblasts and renin-angiotensin-aldosterone system, and depletion of adenosine triphosphate. Moreover, existing therapies only retard the disease progression but do not prevent or reverse it. Therefore, novel modes of pharmacotherapeutic intervention are in demand to targ
作者: LAP    時(shí)間: 2025-3-27 17:15
Hydrogen Sulfide for the Treatment of Hypertensive Nephropathy and Calcium-Based Nephrolithiasis,n monoxide, has been recognized and established to possess antihypertensive and renoprotective properties, which may represent an important therapeutic alternative for hypertensive nephropathy. In this chapter, recent findings from preclinical studies about the therapeutic effect of H.S against hype
作者: 植物學(xué)    時(shí)間: 2025-3-27 19:55
Hydrogen Sulfide as a Potential Therapy for COVID-19-Associated Nephropathy,ulfide (H.S), the third established member of gasotransmitter family, is emerging as a potential candidate, possessing important therapeutic properties including antiviral, anti-inflammatory, antithrombotic, and antioxidant properties. A recent clinical study revealed higher serum H.S levels in surv
作者: enterprise    時(shí)間: 2025-3-28 00:42
Hydrogen Sulfide for Prevention of Obstructive Nephropathy,l anti-inflammatory medications, opioids, and alpha-receptor blockers. However, there is no evidence that they mitigate renal injury. Therefore, identifying potential therapies that could be administered during obstruction may help to improve renal function following decompression. Scientific eviden
作者: Atrium    時(shí)間: 2025-3-28 04:29

作者: PANT    時(shí)間: 2025-3-28 09:05
Hydrogen Sulfide Against Ischemia-Reperfusion Injury in Transplantation of Kidney and Other Transpllation. Our findings in this chapter showed that storage of renal graft and other solid organ grafts in H.S-supplemented preservation solution or administration of H.S to organ donor prior to organ procurement and to recipient at the start and during reperfusion is a novel, simple, and cost-effectiv
作者: arboretum    時(shí)間: 2025-3-28 11:57
nt feature, which is used as the optimal feature subset to train SVM classifier. Finally, the feature subset with the highest SVM classification accuracy was regarded as optimal feature subset. The experimental results on 11 UCI datasets, a real clinical data sets and a gene expression dataset show
作者: 龍卷風(fēng)    時(shí)間: 2025-3-28 15:17

作者: 背帶    時(shí)間: 2025-3-28 21:54
George J. Dugbartey applied iteratively. In some cases, our standardisation approach results in multiple structures for a given compound, in which case a random walk-based algorithm is used to select the most likely structure among incompatible alternates. We applied . to the . model, resolving a unique chemical struc
作者: ear-canal    時(shí)間: 2025-3-29 02:17

作者: 共和國(guó)    時(shí)間: 2025-3-29 05:45

作者: 繁重    時(shí)間: 2025-3-29 09:34

作者: 緊張過度    時(shí)間: 2025-3-29 11:48
George J. Dugbartey,Karl K. Alornyo,Vincent Boima,Sampson Antwi,Alp Senert NNI based local search heuristics for unrooted GTP problems, which enable analyses for thousands of genes. Further, analysis of a large plant data set using the unrooted NNI search provides support for an intriguing new hypothesis regarding the evolutionary relationships among major groups of flow




歡迎光臨 派博傳思國(guó)際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
甘孜| 勃利县| 墨竹工卡县| 云安县| 望谟县| 嫩江县| 武邑县| 海南省| 胶南市| 香河县| 永平县| 松江区| 札达县| 镶黄旗| 自贡市| 稷山县| 南召县| 昭通市| 修水县| 江安县| 靖州| 湘乡市| 香格里拉县| 惠来县| 中西区| 内黄县| 六盘水市| 遵义市| 苗栗市| 胶州市| 宁城县| 沁阳市| 芜湖市| 上蔡县| 凌源市| 嘉祥县| 平邑县| 清丰县| 固原市| 宜黄县| 治县。|